Employment in refractory myasthenia gravis: A Myasthenia Gravis Foundation of America Registry analysis.

"CONFLICT OF INTEREST L.H. was formerly employed by and holds stocks in Alexion Pharmaceuticals, Inc; I.B.A., and G.C. are employed by the University of Alabama at Birmingham, which received financial support from Alexion for this study; H.X. was formerly employed by the University of Alabama at Birmingham. G.C. is also president of Pythagoras, Inc, a private consulting company located in Birmingham, Alabama, and Professor of Biostatistics at the School of Public Health at the University of Alabama at Birmingham. G.C. has served as a member of consulting or advisory boards (Argenix, Atara Biotherapeutics, Axon, Biogen, Brainstorm Cell Therapeutics, Charleston Laboratories, Click Therapeutics, Genentech, Genzyme, GW Pharmaceuticals, Klein Buendel, MedDay Pharmaceuticals, MedImmune, Novartis, Roche, Scifluor Life Sciences, Somahlution, Teva, TG Therapeutics, and UT Houston) and data and safety monitoring boards (AMO Pharma, BioLineRx, Hisun USA, Horizon Pharma, Merck, Merck/Pfizer, Neurim Pharmaceuticals, National Heart, Lung, and Blood Institute [protocol review committee], National Institute of Child Health and Human Development [OPRU oversight committee], Novartis, Orphazyme, OPKO Biologics, Reata Pharmaceuticals, Receptos/Celgene, Sanofi‐Aventis, Teva)."

"Funding information Alexion Pharmaceuticals"